Ken Tanikawa

988 total citations
43 papers, 651 citations indexed

About

Ken Tanikawa is a scholar working on Surgery, Epidemiology and Oncology. According to data from OpenAlex, Ken Tanikawa has authored 43 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 16 papers in Epidemiology and 14 papers in Oncology. Recurrent topics in Ken Tanikawa's work include Liver Disease Diagnosis and Treatment (11 papers), Pediatric Hepatobiliary Diseases and Treatments (10 papers) and Drug Transport and Resistance Mechanisms (10 papers). Ken Tanikawa is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Pediatric Hepatobiliary Diseases and Treatments (10 papers) and Drug Transport and Resistance Mechanisms (10 papers). Ken Tanikawa collaborates with scholars based in Japan, Spain and United Kingdom. Ken Tanikawa's co-authors include Masayoshi Kage, Reiichiro Kondo, Hirohisa Yano, Osamu Nakashima, Yoriko Nomura, Yoshiaki Tanaka, Sadataka Inuzuka, Minoru Yagi, Rin Yamaguchi and Hiroyuki Kusuhara and has published in prestigious journals such as Gut, Scientific Reports and The Journal of Pediatrics.

In The Last Decade

Ken Tanikawa

41 papers receiving 635 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ken Tanikawa Japan 15 297 216 214 205 104 43 651
Xiaochun Ma China 5 136 0.5× 213 1.0× 161 0.8× 228 1.1× 171 1.6× 8 574
Hermien Hartog Netherlands 14 239 0.8× 141 0.7× 151 0.7× 95 0.5× 193 1.9× 50 676
Andrea Thueringer Austria 11 156 0.5× 116 0.5× 154 0.7× 181 0.9× 103 1.0× 13 490
Y. Kamiyama Japan 15 335 1.1× 166 0.8× 282 1.3× 247 1.2× 93 0.9× 47 742
Hiroyuki Muro Japan 16 338 1.1× 114 0.5× 181 0.8× 123 0.6× 127 1.2× 41 687
Kazuhide Takata Japan 10 239 0.8× 63 0.3× 139 0.6× 178 0.9× 120 1.2× 54 577
Hans Ditschuneit Germany 18 476 1.6× 112 0.5× 306 1.4× 293 1.4× 250 2.4× 26 950
Hisao Nakasaki Japan 15 263 0.9× 246 1.1× 94 0.4× 47 0.2× 124 1.2× 67 662
G Sauter Germany 14 450 1.5× 239 1.1× 97 0.5× 175 0.9× 111 1.1× 29 718
Yoshihiro Kanbara Japan 13 111 0.4× 117 0.5× 297 1.4× 436 2.1× 144 1.4× 30 739

Countries citing papers authored by Ken Tanikawa

Since Specialization
Citations

This map shows the geographic impact of Ken Tanikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Tanikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Tanikawa more than expected).

Fields of papers citing papers by Ken Tanikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Tanikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Tanikawa. The network helps show where Ken Tanikawa may publish in the future.

Co-authorship network of co-authors of Ken Tanikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Tanikawa. A scholar is included among the top collaborators of Ken Tanikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Tanikawa. Ken Tanikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kondou, Hiroki, Satoshi Nakano, Tadahaya Mizuno, et al.. (2024). Clinical symptoms, biochemistry, and liver histology during the native liver period of progressive familial intrahepatic cholestasis type 2. Orphanet Journal of Rare Diseases. 19(1). 57–57.
2.
Watanabe, Jirô, Keita Kai, Ken Tanikawa, et al.. (2019). Primary mucoepidermoid carcinoma of the liver with CRTC1-MAML2 fusion: a case report. Diagnostic Pathology. 14(1). 84–84. 12 indexed citations
3.
Imagawa, Kazuo, Hisamitsu Hayashi, Ken Tanikawa, et al.. (2018). Clinical phenotype and molecular analysis of a homozygous ABCB11 mutation responsible for progressive infantile cholestasis. Journal of Human Genetics. 63(5). 569–577. 11 indexed citations
4.
Togawa, Takao, Tatsuki Mizuochi, Tokio Sugiura, et al.. (2018). Clinical, Pathologic, and Genetic Features of Neonatal Dubin-Johnson Syndrome: A Multicenter Study in Japan. The Journal of Pediatrics. 196. 161–167.e1. 28 indexed citations
5.
Yamamoto, Ryoko, Ken Tanikawa, Hideki Shiratsuchi, et al.. (2017). Dietary D-Allose Ameliorates Hepatic Inflammation in Mice with Non-alcoholic Steatohepatitis. Food Science and Technology Research. 23(2). 319–327. 8 indexed citations
6.
Akiba, Jun, Osamu Nakashima, Satoshi Hattori, et al.. (2016). The expression of arginase-1, keratin (K) 8 and K18 in combined hepatocellular-cholangiocarcinoma, subtypes with stem-cell features, intermediate-cell type. Journal of Clinical Pathology. 69(10). 846–851. 21 indexed citations
7.
Naoi, Sotaro, Hisamitsu Hayashi, Takeshi Inoue, et al.. (2014). Improved Liver Function and Relieved Pruritus after 4-Phenylbutyrate Therapy in a Patient with Progressive Familial Intrahepatic Cholestasis Type 2. The Journal of Pediatrics. 164(5). 1219–1227.e3. 54 indexed citations
8.
Yagi, Minoru, Suguru Fukahori, Yoshiaki Tanaka, et al.. (2013). Infantile neuroblastoma of the urinary bladder detected by hematuria. Pediatric Surgery International. 29(7). 753–757. 3 indexed citations
9.
Akiba, Jun, Osamu Nakashima, Satoshi Hattori, et al.. (2013). Clinicopathologic Analysis of Combined Hepatocellular-Cholangiocarcinoma According to the Latest WHO Classification. The American Journal of Surgical Pathology. 37(4). 496–505. 112 indexed citations
10.
Yagi, Minoru, et al.. (2011). The herbal medicine Inchinko-to reduces hepatic fibrosis in cholestatic rats. Pediatric Surgery International. 28(4). 379–384. 14 indexed citations
11.
Kobayashi, Hiroharu, Yoshiaki Tanaka, Tomohiro Asakawa, et al.. (2010). The antioxidant effect of green tea catechin ameliorates experimental liver injury. Phytomedicine. 17(3-4). 197–202. 42 indexed citations
12.
Tanaka, Yoshiaki, et al.. (2008). Oxidative stress profile in the post-operative patients with biliary atresia. Pediatric Surgery International. 25(1). 93–97. 10 indexed citations
13.
Tanikawa, Ken, Masayoshi Kage, Mina Komuta, et al.. (2007). Pathological analysis of oxyphilic granular hepatocytes and hepatocellular mitochondria in chronic hepatitis C. Hepatology Research. 37(6). 425–432.
14.
Tanaka, Yoshiaki, et al.. (2003). Clinical Significance of Plasma Diamine Oxidase Activity in Pediatric Patients: Influence of Nutritional Therapy and Chemotherapy. The Kurume Medical Journal. 50(3/4). 131–137. 13 indexed citations
15.
ABE, Hirohiko, Yoshiyuki Miyahara, Yasuhiro Uchimura, et al.. (1998). Two Cases of Adult Varicella Accompanied by Hepatic Dysfunction. Kansenshogaku zasshi. 72(4). 418–423. 5 indexed citations
16.
Kishimoto, Shinji, Hironori Kobayashi, Goro Kajiyama, et al.. (1990). Further Study of Mucosal Repair by Sofalcone in Experimental Gastritis. Journal of Clinical Gastroenterology. 12. S181–S186. 1 indexed citations
17.
Yoshino, Makoto, et al.. (1990). Ornithine Transcarbamylase Deficiency in Male Adolescenceand Adulthood. Enzyme. 43(3). 160–168. 26 indexed citations
18.
Harada, Mayumi, et al.. (1990). [A case of secondary hemochromatosis, in which MRI is useful to evaluate therapeutic effect].. PubMed. 35(9). 1081–4. 1 indexed citations
19.
Tanikawa, Ken, Abe H, Koji Takeuchi, et al.. (1978). [Treatment of gallstone with ursodeoxycholic acid--lipid and bile acid composition in bile (author's transl)].. PubMed. 75(8). 1196–203. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026